YourChoice Therapeutics CEO Akash Bakshi (left) and CSO Nadja Mannowetz

Ex­clu­sive: Af­ter Covid piv­ot, biotech nabs funds to be first in the clin­ic with a non-hor­mon­al con­tra­cep­tive for men

The goal was to cre­ate a non-hor­mon­al con­tra­cep­tive that women could take to pre­vent preg­nan­cy and po­ten­tial­ly STIs, but the Covid-19 pan­dem­ic caused Your­Choice Ther­a­peu­tics …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.